The pathogenic role of different Blastocystis hominis genotypes isolated from patients with irritable bowel syndrome

Arab Journal of Gastroenterology

Volumn 12, Issue 4, 2011, Pages 194-200

  Fouad, Shawky A ^a   Basyoni, Maha M A ^a   Fahmy, Reham A ^a   Kobaisi, Mohamed H ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b National Institute of Urology and Nephrology   (Egypt)

Author keywords

Blastocystis hominis; Genotypes; IBS

Indexed keywords

ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BLASTOCYSTIS HOMINIS; CHRONIC INFLAMMATION; COLON BIOPSY; CONTROLLED STUDY; DISEASE SEVERITY; FECES ANALYSIS; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIGMOIDOSCOPY; SMEAR;

ADOLESCENT; ADULT; ANIMALS; BLASTOCYSTIS HOMINIS; BLASTOCYSTIS INFECTIONS; DNA, PROTOZOAN; FECES; FEMALE; GENOTYPE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84856514096     PISSN: 16871979     EISSN: 20902387     Source Type: Journal    
DOI: 10.1016/j.ajg.2011.11.005     Document Type: Article

References (36)

1. Wong K.H.S., Ng G.C., Lin R.T.P., et al. Predominance of subtype 3 among Blastocystis isolates from a major hospital in Singapore. Parasitol Res 2008, 102(4):663-670.
2. Ramirez Miranda M.E., Hernandez Castellanos R., Lopez Escamilla E., et al. Parasites in Mexican patients with irritable Bowel syndrome: a case-control study. Parasites Vectors 2010, 3(1). [Art. No. 96].
3. Tan K.S.W. New insights on classification, identification and clinical relevance of Blastocystis spp. Clin Microbiol Rev 2008, 21(4):639-665.
4. Drossman D.A., Whitehead W.E., Camilleri M. Irritable Bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997, 112(6):2120-2137.
5. Thompson W.G., Creed F., Drossman D.A., et al. Functional Bowel disease and functional abdominal pain. Gastroenterol Int 1992, 5(2):75-91.
6. Longstreth G.F., Thompson W.G., Chey W.D., et al. Functional bowel disorders. Gastroenterology 2006, 130(5):1480-1491.
7. Hussain R., Jaferi W., Zuberi S., et al. Significantly increased IgG2 subclass antibody levels to Blastocystis hominis in patients with irritable bowel syndrome. Am J Trop Med Hyg 1997, 56(3):301-306.
8. Rossignol J.F., Kabil S.M., Said M., et al. Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis. Clin Gastroenterol Hepatol 2005, 3(10):987-991.
9. Stark D., van Hal S., Marriott D., et al. Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis. Int J Parasitol 2007, 37(1):11-20.
10. Cruz Licea V., Plancarte Crespo A., Morán álvarez C., et al. Blastocystis hominis among food vendors in xochimilco markets. Rev Latinoam Microbiol 2003, 45(1-2):12-15.
11. Tan K.S.W., Singh M., Yap E.H. Recent advances in Blastocystis hominis research: hot spots in terra incognita. Int J Parasitol 2002, 32(7):789-804.
12. Li L.H., Zhou X.N., Du Z.W., et al. Molecular epidemiology of human Blastocystis in a village in Yunnan Province, China. Parasitol Int 2007, 56(4):281-286.
13. Yan Y., Su S., Lai R., et al. Genetic variability of Blastocystis hominis isolates in China. Parasitol Res 2006, 99(5):597-601.
14. Zaman V. Phase-contrast microscopy of cell division in Blastocystis hominis. Ann Trop Med Parasitol 1997, 91(2):223-224.
15. Eroglu F., Genc A., Elgun G., et al. Identification of Blastocystis hominis isolates from asymptomatic and symptomatic patients by PCR. Parasitol Res 2009, 105(6):1589-1592.
16. Dogruman Al F., Dagci H., Yoshikawa H., et al. A possible link between subtype 2 and asymptomatic infections of Blastocystis hominis. Parasitol Res 2008, 103(3):685-689.
17. Cenac N., Andrews C.N., Holzhausen M., et al. Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest 2007, 117(3):636-647.
18. Gecse K., Róka R., Ferrier L., et al. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity. Gut 2008, 57(5):591-598.
19. Puthia M.K., Vaithilingam A., Lu J., et al. Degradation of human secretory immunoglobulin a by Blastocystis. Parasitol Res 2005, 97(5):386-389.
20. Rayan H.Z., Ismail O.A., El Gayar E.K. Prevalence and clinical features of Dientamoeba fragilis infections in patients suspected to have intestinal parasitic infection. J Egypt Soc Parasitol 2007, 37(2):599-608.
21. Yoshikawa H., Wu Z., Kimata I., et al. Polymerase chain reaction-based genotype classification among human Blastocystis hominis populations isolated from different countries. Parasitol Res 2004, 92(1):22-29.
22. Parkar U., Traub R.J., Kumar S., et al. Direct characterization of Blastocystis from faeces by PCR and evidence of zoonotic potential. Parasitology 2007, 134(3):359-367.
23. Noël C., Dufernez F., Gerbod D., et al. Molecular phylogenies of Blastocystis isolates from different hosts: implications for genetic diversity, identification of species and zoonosis. J Clin Microbiol 2005, 43(1):348-355.
24. Kaneda Y., Horiki N., Cheng X.J., et al. Ribodemes of Blastocystis hominis isolated in Japan. Am J Trop Med Hyg 2001, 65(4):393-396.
25. Elwakil H.S., Talaat R.M. Genetic analysis of Blastocystis hominis isolated from symptomatic and asymptomatic human hosts in Egypt. J Egypt Soc Parasitol 2009, 39(1):99-109.
26. Böhm Gloning B., Knobloch J., Walderich B. Five subgroups of Blastocystis hominis isolates from symptomatic and asymptomatic patients revealed by restriction site analysis of PCR-amplified 16S-like rDNA. Trop Med Int Health 1997, 2(8):771-778.
27. Souppart L., Moussa H., Cian A., et al. Subtype analysis of Blastocystis isolates from symptomatic patients in Egypt. Parasitol Res 2010, 106(2):505-511.
28. Gallagher P.G., Venglarcik J.S. Blastocystis hominis enteritis. Pediatr Infect Dis 1985, 4(5):556-557.
29. Guglielmetti P., Cellesi C., Figura N., et al. Family outbreak of Blastocystis hominis associated gastroenteritis. Lancet 1989, 2(8676):1394.
30. Al Tawil Y.S., Gilger M.A., Gopalakrishna G.S., et al. Invasive Blastocystis hominis infection in a child. Arch Pediatr Adolesc Med 1994, 148(8):882-885.
31. Zuckerman M.J., Watts M.T., Ho H., et al. Blastocystis hominis infection and intestinal injury. Am J Med Sci 1994, 308(2):96-101.
32. Dagci H., Ustun S., Taner M.S., et al. Protozoon infections and intestinal permeability. Acta Trop 2002, 81(1):1-5.
33. Dunlop S.P., Hebden J., Campbell E., et al. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol 2006, 101(6):1288-1294.
34. Kirsch R.H., Riddell R. Histopathological alterations in irritable bowel syndrome. Mod Pathol 2006, 19(12):1638-1645.
35. Hussein E.M., Hussein A.M., Eida M.M., et al. Pathophysiological variability of different genotypes of human Blastocystis hominis Egyptian isolates in experimentally infected rats. Parasitol Res 2008, 102(5):853-860.
36. Denoeud F., Roussel M., Noel B., et al. Genome sequence of the stramenopile Blastocystis, a human anaerobic parasite. Genome Biol 2011, 12(3):R29.